SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Braddock Bull who wrote (2547)2/26/1998 12:00:00 PM
From: Dr. Voodoo  Read Replies (1) of 7041
 
BB, another $.02 I thought I'd throw in.

It's quite possible that Immumax is alot like Vasomax, in that the patent positions they tried(and will probably try to in the future) are tenuous.

In the case of the patent for Vasomax that they are trying to file now, their are only minor novelties in there discovery. Phentolamine was known, rapid gut absorption could be inferred, and oral phentolamine as a therapy for ED was known. One could certainly argue that they have done nothing new.

Immumax appears to have been a very similar deal. Remember the Immumax charges are claims in an ancillary lawsuit, and are likely to be highly succeptible to individual interpretation.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News